The aim of the study was to determine whether use of fluorescence bronchoscopy improves the detection of preinvasive neoplastic bronchial lesions. The data of all patients who underwent fluorescence bronchoscopy and in whom bronchial biopsies were taken, were analyzed. Most patients were at risk for preinvasive lesions. A total of 174 bronchoscopies were performed in 95 patients. Of the 681 representative biopsies, 31 were found to be moderate dysplastic, 39 were found to be severe dysplastic and 9 exhibited carcinoma in situ. These 79 preinvasive lesions were found in 34 patients. The respective results of fluorescence bronchoscopy in addition to conventional bronchoscopy and of conventional bronchoscopy alone for detection of preinvasive lesions were: sensitivity 85% (67/79) and 59% (47] 
INTRODUCTION
Squamous cell carcinoma of the bronchus is thought to arise after a series of progressive histologic changes in the bronchial epithelium [1] .
These preinvasive neoplastic lesions are, in order of increasing severity: basal cell hyperplasia, metaplasia, mild, moderate and severe dysplasia, and 78 B.J.W. VENMANS et al. carcinoma in situ. When the bronchial mucosa is illuminated by a blue light with a wavelength of 405-442nm, such as light from a Krypton ion laser or a Helium-Cadmium laser, there is a progressive reduction in the green wavelength band of the autofluorescence spectrum as the tissue becomes more neoplastic [2, 3] . Based on this difference in fluorescence intensity, the lung imaging fluorescence endoscope (LIFE) system (Xillix Technologies Corp; Richmond, BC, Canada) was developed to detect preinvasive bronchial lesions [4, 5] . LIFE provides true fluorescence images in real time. Normal tissue which fluoresces green, can be distinguished from neoplastic tissue which appears to be brown or brownish red in color depending on the pathology grade. Experience with the LIFE system has shown that it can improve the detection rate of preinvasive bronchial lesions compared with conventional bronchoscopy. Lam et al. [5] found the sensitivity of LIFE to be twice the sensitivity of conventional bronchoscopy for the detection of preinvasive bronchial lesions. Fluorescence bronchoscopy could therefore be clinically useful in detecting and localizing early lung cancer, in staging the extent of endobronchial spread of bronchial cancer and in detecting synchronous roentgenographically occult cancer. Early detection may improve the prognosis of lung cancer patients, since it was shown that early treatment as surgical resection or bronchoscopic treatment for roentgenographically occult intraluminal tumors gives the best chance for cure [6] [7] [8] [9] [10] [11] [12] [13] [14] . We started using the LIFE system in clinical practice in November 1995. The aim of this study was to determine whether use of the LIFE system improves the detection of preinvasive bronchial lesions. Preinvasive lesions were defined as lesions that were scored by the pathologist as moderate dysplasia, severe dysplasia or carcinoma in situ. These preinvasive lesions were considered clinically important in the population at risk, and were considered to be the interest of using a LIFE system for early tumor detection.
MATERIALS AND METHODS

Bronchoscopy
All the patients from the Department of Pulmon- 
Histological Examination
The biopsies were processed in a routine fashion. After fixation for at least 24h in 4% buffered formalin, the tissue was blocked in paraffin and 4gm slides were mounted on glass and stained with hematoxylin and eosin using standard procedure. The pathologists reported the results of microscopy of all specimens in separate jars, by indicating them to be: unsatisfactory, normal, inflammation, hyperplasia, mild dysplasia, moderate dysplasia, severe dysplasia, carcinoma in situ, and carcinoma.
Analysis
The results of the histologic examination were compared with the results of the visual assessment using the conventional and the LIFE cameras.
Sensitivity, specificity, positive and negative predictive values for detection of the total number of moderate dysplasias, severe dysplasias and carcinomas in situ were calculated. The relative sensitivity, or the ratio of the sensitivity of conventional bronchoscopy combined with LIFE, as compared with conventional bronchoscopy alone, along with the 95% confidence interval (CI), was calculated to evaluate the contribution of fluorescence examination to detect preinvasive lesions.
The results of all bronchoscopies using the LIFE system were analyzed. In a subgroup of patients several LIFE bronchoscopies were done. Because patient selection may influence the results, a separate analysis was performed using only the first bronchoscopy data of each patient. This second analysis was also used to examine if there is a learning effect in using the LIFE system. We therefore compared the results of the first 48 patients with the results obtained in the next 47 consecutive patients.
RESULTS
Patients demographics and bronchoscopy data are shown in Table I . A total of 174 bronchoscopies were performed in 95 patients. All procedures were completed under local anesthesia and no complications were observed during or after bronchoscopic examination. The median duration of the additional LIFE examination was 15 min (range: 5-25 min). Of the total number of biopsies taken, 92% (681/742) was judged by the pathologists to be satisfactory, enabling adequate assessment of the morphology. Three-hundred-and-two of these 681 biopsies were taken based on suspicious findings during LIFE bronchoscopy. Onehundred-and-fourty of these 302 biopsies were In recent studies sensitivities of 90% and 67% in detecting (pre)invasive lesions were reported [22, 23] . However, the specificities when using the LIFE system were lower in the present study (60-69% [26] [27] [28] . The fluorescence pattern RESULTS OF FLUORESCENCE BRONCHOSCOPY 83 of the bronchial mucosa may therefore reflect [4] molecular genetic changes which are beyond the threshold of the macroscopic and microscopic [5] abilities of the bronchoscopist and the pathologist.
By using current technique and histological criteria as the golden standard for diagnosing preinva- [6] sive lesions, the clinical impact of molecular genetic changes and its relation to tissue auto- [7] fluorescence remains elusive. A subgroup of patients underwent several LIFE bronchoscopies. [8] To exclude that patient selection bias may influence the results, a separate analysis was performed [9] using only the first bronchoscopy of each patient.
The results of this analysis were comparable to those of all the bronchoscopies. The number of [10] preinvasive lesions found with LIFE was higher and the best results were obtained when both [111 modalities were combined. Both analyses showed that specificity and positive predictive were lower when LIFE was used and that a high sensitivity [12] can be obtained by conventional bronchoscopy alone. To study if" there was a learning effect in using the LIFE system the results of the first bronchoscopies of the first half of the patient [13] group were compared with the results obtained in the second half. Sensitivity, specificity, positive [141 predictive value and negative predictive value all were higher in the second half of the patient group. This indicates a learning effect in using the LIFE system. We conclude that fluorescence [15] bronchoscopy can be performed safely and that after a learning period it can increase the yield of finding preinvasive neoplastic lesions when used [16] in addition to conventional bronchoscopy.
